Combining epigenetic and immune checkpoint inhibitors in bladder cancer

被引：0
|
作者：
Clemens Thoma
机构：
[1] Nature Reviews Urology,
来源：
Nature Reviews Urology | 2019年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：507 / 507
相关论文
共 50 条
  • [1] Combining epigenetic and immune checkpoint inhibitors in bladder cancer
    Thoma, Clemens
    [J]. NATURE REVIEWS UROLOGY, 2019, 16 (09) : 507 - 507
  • [2] Immune checkpoint inhibitors for metastatic bladder cancer
    Cubelli, Marta
    Di Nunno, Vincenzo
    Rihawi, Karim
    Massari, Francesco
    [J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S720 - S732
  • [3] Immune checkpoint inhibitors for metastatic bladder cancer
    Massari, Francesco
    Di Nunno, Vincenzo
    Cubelli, Marta
    Santoni, Matteo
    Fiorentino, Michelangelo
    Montironi, Rodolfo
    Cheng, Liang
    Lopez-Beltran, Anto
    Battelli, Nicola
    Ardizzoni, Andrea
    [J]. CANCER TREATMENT REVIEWS, 2018, 64 : 11 - 20
  • [4] Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
    Lopez-Beltran, Antonio
    Cimadamore, Alessia
    Blanca, Ana
    Massari, Francesco
    Vau, Nuno
    Scarpelli, Marina
    Cheng, Liang
    Montironi, Rodolfo
    [J]. CANCERS, 2021, 13 (01) : 1 - 16
  • [5] Combining immune Checkpoint inhibitors with Conventional Cancer Therapy
    Yan, Yiyi
    Kumar, Anagha Bangalore
    Finnes, Heidi
    Markovic, Svetomir N.
    Park, Sean
    Dronca, Roxana S.
    Dong, Haidong
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [6] Immune checkpoint inhibitors: a new frontier in bladder cancer
    Kates, Max
    Sopko, Nikolai A.
    Matsui, Hotaka
    Drake, Charles G.
    Hahn, Noah M.
    Bivalacqua, Trinity J.
    [J]. WORLD JOURNAL OF UROLOGY, 2016, 34 (01) : 49 - 55
  • [7] Immune checkpoint inhibitors: a new frontier in bladder cancer
    Max Kates
    Nikolai A. Sopko
    Hotaka Matsui
    Charles G. Drake
    Noah M. Hahn
    Trinity J. Bivalacqua
    [J]. World Journal of Urology, 2016, 34 : 49 - 55
  • [8] Combining TNF blockade with immune checkpoint inhibitors in patients with cancer
    Montfort, Anne
    Virazels, Mathieu
    Colacios, Celine
    Meyer, Nicolas
    Segui, Bruno
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2021, 17 (09) : 577 - 577
  • [9] Immune Checkpoint Inhibitors for Kidney and Bladder Cancer: Adrenotoxic Consequences
    Liblik, Kiera
    Caterini, Jessica
    Touma, Naji J.
    [J]. UROLOGY, 2024, 187 : 114 - 118
  • [10] IMMUNE CHECKPOINT INHIBITORS FOR KIDNEY AND BLADDER CANCER: ADRENOTOXIC CONSEQUENCES
    Liblik, Kiera
    Caterini, Jessica
    Touma, Naji
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E528 - E528
12345